Comparison of the pharmacokinetics between intramuscular and subcutaneous manual epinephrine administration

Ann Allergy Asthma Immunol. 2023 Apr;130(4):515-516. doi: 10.1016/j.anai.2022.12.010. Epub 2022 Dec 13.

Authors

Sarina Tanimoto¹, Michael Kaliner², Anne K Ellis³, Richard Lowenthal⁴

Affiliations

¹ Department of Clinical Development and Medical Affairs, ARS Pharmaceuticals, Inc., San Diego, California. Electronic address: sarinat@ars-pharma.com.
² Medical Director, Institute for Asthma and Allergy, Rockville, Maryland.
³ Division of Allergy & Immunology, Department of Medicine, Queen's University, Kingston, Ontario, Canada.
⁴ Department of Clinical Development and Medical Affairs, ARS Pharmaceuticals, Inc., San Diego, California.

PMID: 36521787
DOI: 10.1016/j.anai.2022.12.010

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Letter

MeSH terms

Anaphylaxis* / drug therapy
Epinephrine* / therapeutic use
Humans
Injections, Intramuscular
Injections, Subcutaneous

Substances

Epinephrine